Replies to post #139669 on Biotech Values

[DewDiligence]

THRX—I don't get it; don’t see Relovair advantage.

I don’t either, as noted in #msg-73611681.

If anyone here understands the rationale for GSK’s increasing its stake in THRX, please chime in.